Overall rank by patents
#8,937
Across all tracked assignees
USPTO PatentsView assignee record - 36 granted patents across 31 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08L (COMPOSITIONS OF MACROMOLECULAR COMPOUNDS).
The verdict
Toyobo holds 36 US patents across 31 technology areas, rank #8,937 of 50,000 tracked assignees.
Toyobo MC Corporation has been granted 36 US utility patents between 2023 and 2025, placing Toyobo MC Corporation at rank #8,937 across all assignees tracked by PlainPatent. This portfolio spans 31 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.3 claims per patent with primary concentration in C08L (COMPOSITIONS OF MACROMOLECULAR COMPOUNDS). As a Foreign Corporation, Toyobo MC Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Toyobo sits between Synthetic Biologics, Inc. (36 patents, rank #8,933) and Targus International Llc (36 patents, rank #8,941) - the closest US assignees by grant volume. The composite Innovation Score of 57.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 36 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Toyobo MC Corporation's 8.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 31 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Toyobo MC Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Synthetic Biologics, Inc.
36 patents
TALARI NETWORKS INCORPORATED
36 patents
TECMEN ELECTRONICS CO., LTD
36 patents
THE HC COMPANIES, INC
36 patents
TRANSMEDICS, INC.
36 patents
TRUMPF Werkzeugmaschinen SE + Co. KG
36 patents
Taiwan Green Point Enterprises Co., Ltd.
36 patents
Targus International LLC
36 patents
TOYOBO MC CORPORATION
36 patents
What this shows Toyobo holds 36 patents at rank #8,937, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #8,937 in granted patent volume.
Other assignees with the most granted patents in Toyobo's primary technology class.
Toyobo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
57 Top 5% higher than 95% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 4 | 11.1% |
| 2024 | 16 | 44.4% |
| 2025 | 16 | 44.4% |
Top 15 of 31 technology areas
Overall rank by patents
#8,937
Across all tracked assignees
57.2 out of 100
How to use this portfolio
Toyobo's 36 grants land it in the top 5% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.